CUSIP 92764N102COMVIRQ4 2025
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradeQ4 2025
216 funds hold this security · Q4 2025
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Blackrock, Inc. | 16.33M | $98.47M | +362.4K | Added |
| 2 | Sb Investment Advisers (Uk) Ltd | 13.12M | $79.10M | −3.57M | Reduced |
| 3 | Arch Venture Management, LLC | 12.92M | $77.89M | 0 | Held |
| 4 | Vanguard Group Inc | 12.55M | $75.67M |
| −250.4K |
| Reduced |
| 5 | Gsk PLC | 8.55M | $51.56M | +8.55M | New Position |
| 6 | State Street Corp | 6.23M | $37.56M | +988.3K | Added |
| 7 | Fmr LLC | 3.16M | $19.05M | −478.7K | Reduced |
| 8 | Morgan Stanley | 2.68M | $16.16M | −10.0K | Reduced |
| 9 | Dimensional Fund Advisors LP | 2.54M | $15.29M | −442.6K | Reduced |
| 10 | Orbimed Advisors LLC | 2.38M | $14.36M | 0 | Held |
See every fund holding Vir Biotechnology Inc, with full quarter-over-quarter share changes.
Unlock all holders